| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Rastetter William H is a Director at DARE with holdings across 3 companies. Recent SEC Form 4 filings include 1 buy and 10 sells.
Estimated insider holdings value: $9.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 5, 2025 | NBIX Neurocrine Biosciences Inc | Director | Sale+OE | 18,000 | $151.82 | $2,732,689.80 | -30.8% | -9.6% | - | |
| May 5, 2025 | NBIX Neurocrine Biosciences Inc | Director | Sale+OE | 30,000 | $110.20 | $3,305,952.00 | -44.5% | +16.7% | +20.1% | |
| Aug 15, 2024 | NBIX Neurocrine Biosciences Inc | Director | Sell | 14,250 | $146.69 | $2,090,332.50 | -27.5% | -15.1% | -10.1% | |
| Jan 2, 2024 | NBIX Neurocrine Biosciences Inc | Director | Sale+OE | 11,044 | $131.47 | $1,451,927.07 | -17.6% | +7.3% | +4.7% | |
| May 1, 2023 | NBIX Neurocrine Biosciences Inc | Director | Sale+OE | 4,300 | $101.43 | $436,135.24 | -9.1% | -2.0% | +32.2% | |
| Apr 21, 2023 | NBIX Neurocrine Biosciences Inc | Director | Sale+OE | 6,937 | $105.03 | $728,605.23 | -8.6% | -6.0% | +26.7% | |
| Apr 1, 2022 | NBIX Neurocrine Biosciences Inc | Director | Sale+OE | 10,728 | $94.93 | $1,018,366.13 | -24.0% | +2.0% | +5.9% | |
| Jan 24, 2018 | NBIX Neurocrine Biosciences Inc | Director | Sale+OE | 9,500 | $90.00 | $855,000.00 | -27.7% | - | - | |
| Feb 1, 2017 | NBIX Neurocrine Biosciences Inc | Director | Sale+OE | 10,750 | $42.28 | $454,510.00 | -43.0% | - | - | |
| Nov 23, 2016 | FATE Fate Therapeutics Inc | Director | Buy | 375,939 | $2.66 | $999,997.74 | +451.1% | - | - |